Our latest products
-
GEFTICAP-250MG Gefitinib
₹3,800.00₹1,999.00Gefitinib is an oral small molecule EGFR inhibitor that is approved for the therapy of metastatic non-small cell lung cancer. Side effects are usually dose related mild to moderate,
-
SORACAP – 200MG Sorafenib
₹2,800.00₹2,000.00Sorafenib is an oral targeted kinase inhibitor used to treat advanced renal cell carcinoma (kidney cancer), unresectable hepatocellular carcinoma (liver cancer), and radioactive iodine-resistant differentiated thyroid cancer.
-
IMACAP-100MG Imatinib
₹1,400.00₹1,000.00Imatinib is a prescription medication used to treat Acute Lymphoblastic Leukemia, Myelodysplastic/Myeloproliferative Disease, Hypereosinophilic Syndrome and/or Chronic Eosinophilic Leukemia, Chronic Myeloid Leukemia Philadelphia-Chromosome-Positive, Dermatofibrosarcoma Protuberans, Mastocytosis, and Gastrointestinal Stromal Tumors.
-
LENVACAP 4MG – Lenvatinib
₹1,500.00₹1,300.00LENVACAP® (lenvatinib), a prescription medicine that may help treat people with certain kinds of cancer.
-
OSIM-80 Osimertinib
₹2,100.00OSIM-80 (Osimertinib)/ Azd9291 is kinase inhibitor of the epidermal growth factor receptor (EGFR).
-
OSIM-40 Osimertinib
₹1,500.00OSIM-40 Osimertinib is kinase inhibitor of the epidermal growth factor receptor (EGFR).
